- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03761667
Usefulness of NBI for Complete Endoscopic Resection of SSA/P
Usefulness of Narrow Band Imaging (NBI) for Complete Endoscopic Resection of Sessile Serrated Adenoma/Polyp (SSA/P): NASA Study
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This study is a prospective randomized multi-center study to evaluate the role of NBI for improving complete resection rate of sessile serrated adenoma/polyp (SSA/P).
The authors will enroll consecutive patients who underwent colon polypectomy for suspicious SSA/P during colonoscopy.
All patients who undergo polypectomy will be enrolled, but excluded as follows; 1. poor bowel preparation according to Boston bowel preparation scale calculation, 2. inflammatory bowel disease, 3. failure of cecal insertion, 4. continuous anti-plate agents or anti-coagulation agents users.
First, the authors will inspect polyp using the arbitrary endoscopic criteria by inspection of white light endoscopy (WLE) and if that lesion is satisfied with 3 or more than 3 out of 5 categories (1. located in the right colon, 2. flat shape, 3. covered with mucus cap or debris, 4. 1 cm or larger than 1 cm in size, 5. varicose superficial vessel was seen on the surface after submucosal injection), endoscopic resection will be performed.
And then, the authors will inspect the resection margin carefully using NBI or WLE by pre-randomization before endoscopic resection. If the remnant tissue is detected, additional endoscopic resection will be performed.
ed margin as two groups (NBI inspection group and WLE inspection
And then, 4 biopsies from 4 quadrants of margin for evaluation of complete resection.
Primary end-point is comparing the rate of additional resection for remnant lesion, the SSA/P diagnosis rate of the remnant lesions after the additional resection, and the complete resection rate of the target lesion between two groups.
Secondary aim is evaluate the accuracy for SSA/P using arbitrary WLE criteria. For evaluation of the accuracy of arbitrary WLE criteria, the authors will compare the pathologic diagosis rate of SSA/P for each criterion, and calculate the sensitivity, the specificity, the positive predictive value, the negative predictive value, and the accuracy with area under curve of ROC.
The authors hypothesized complete resection rate of SSA/P as 90% in the NBI inspection group and 70% in the WLE inspection group based on previous studies including CARE study.
The sample size was calculated as 118 (each 59) patients of SSA/P. Study duration will be 2 years.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Colonoscopy examinee with suspicious SSA/P
Exclusion Criteria:
- Poor bowel preparation (total Boston bowel preparation scale < 6 or any region score < 2)
- Inflammatory bowel disease
- failed cecal insertion of colonoscopy
- continuous taking anticoagulation or anti-platelet drugs until on the procedure day
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: NBI
The group of NBI inspection on resection margin for surveillance of remnant tissue of SSA/P right after the endoscopic resection.
If the remnant tissue is detected using NIB inspection, additional endoscopic resection should be performed.
|
Inspection of resection margin of SSA/P for the evaluation of complete resection or the presence of remnant lesion using NBI method
|
No Intervention: White light endoscopy (WLE)
The group of WLE inspection on resection margin for surveillance of remnant tissue of SSA/P right after the endoscopic resection.
If the remnant tissue is detected using NIB inspection, additional endoscopic resection should be performed.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
the detection rate of remnant lesion,
Time Frame: 2 years after IRB
|
Comparing the detection rate of remnant SSA/P right after the endoscopic resection
|
2 years after IRB
|
The diagnosis rate of SSA/P in the remnant tissue
Time Frame: 2 years after IRB
|
Pathologic diagnosis rate of SSA/P after the additional endoscopic resection of the remnant tissue detected by NBI or WLE right after the endoscopic resection.
|
2 years after IRB
|
Incomplete resection rate of SSA/P
Time Frame: 2 years after IRB
|
Compare the incomplete resection rate of SSA/P using four directional biopsied on the resection margin after the endoscopic resection including additional resection
|
2 years after IRB
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Accuracy of arbitrary endoscopic criteria for SSA/P inspection by white light endoscopy
Time Frame: 2 years after IRB
|
In this study, the authors made the arbitrary endoscopic criteria for suspicion of SSA/P by inspection of WLE.
|
2 years after IRB
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- NASA
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sessile Serrated Adenoma/Polyps
-
South Tyneside and Sunderland NHS Foundation TrustMedtronic; Newcastle University; North Wales Organisation for Randomised Trials...CompletedColonic Polyp | Colorectal Adenoma | Colorectal Polyp | Colorectal SSA | Colorectal Adenomatous Polyp | Sessile Serrated Adenoma | Sessile Colonic PolypUnited Kingdom
-
Shandong UniversityUnknownColorectal Sessile Serrated Adenomas/PolypsChina
-
University of California, DavisCompletedSessile Serrated AdenomaUnited States
-
Princess Alexandra Hospital, Brisbane, AustraliaRecruiting
-
Hospital Beatriz ÂngeloUnknownColon Cancer | Colon Sessile Serrated Adenoma/PolypPortugal
-
Parc de Salut MarCompletedColorectal Neoplasms | Sessile Serrated Adenoma | Serrated PolypsSpain
-
Western Sydney Local Health DistrictCompletedSessile Serrated AdenomaAustralia
-
Seoul National University HospitalSeoul National UniversityCompletedAdenoma | Colonoscopy | Sessile Serrated AdenomaKorea, Republic of
-
Changhai HospitalThe Second Hospital of Hebei Medical University; Air Force Military Medical... and other collaboratorsRecruitingColorectal Sessile Serrated LesionChina
-
NYU Langone HealthCompletedColorectal Cancer | Serrated Polyp | Sessile Serrated Adenoma | Hyperplastic PolypUnited States
Clinical Trials on Endoscopy using Narrow band imaging
-
Soonchunhyang University HospitalCompletedGastric Intestinal Metaplasia | Narrow-band Imaging | Magnifying EndoscopyKorea, Republic of
-
Soonchunhyang University HospitalCompleted
-
University Hospital OstravaRecruitingLaryngeal Disease | Laryngeal Lesions | Hypopharyngeal Lesions | Suspected Laryngeal Cancer | Suspected Hypopharyngeal Cancer | Proven Laryngeal Cancer | Proven Hypopharyngeal CancerCzechia
-
Changi General HospitalCompletedGastric Cancer | Gastric Intestinal MetaplasiaSingapore
-
Lotung Poh-Ai HospitalTerminated
-
Yonsei UniversityUnknownEarly Gastric Cancer | Gastric Dysplasia | Gastric Adenoma
-
University of CambridgeUnknownBarrett EsophagusUnited Kingdom
-
Tomasz RomańczykCompletedHeterotopic Gastric Mucosa of the Proximal EsophagusPoland
-
Mercy Medical CenterAdvocate Lutheran General Hospital; Olympus America, Inc.CompletedEndometriosisUnited States
-
Parc de Salut MarCompleted